Stay updated on CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for the CAN04 and FOLFIRINOX study is now displayed, including its completed status, eligibility criteria, study locations, and outcome measures, replacing the access-denied page.
    Difference
    51%
    Check dated 2026-11-08T00:22:34.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T18:26:13.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:17:42.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:06:19.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:03:21.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the usual study details with an access-denied message. This indicates that the record cannot be viewed at the moment, affecting users' ability to access study information.
    Difference
    18%
    Check dated 2026-09-19T22:01:08.000Z thumbnail image

Stay in the know with updates to CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.